HESTER BIOSCIENCES
|
|
BOM : 524669     NSE : HESTERBIO     | |
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive] Debt : High |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Downward Pledged Shares : None or < 25% |
Jun 07,2023 |
Price(EOD): βΉ 1,632.65
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: βΉ 1,387.75 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
HESTER BIOSCIENCES | -1.2% | -8.7% | -28.5% |
SUN PHARMACEUTICAL INDUSTRIES | 2.7% | 5.9% | 17.9% |
DIVIS LABORATORIES | 0.5% | 4.8% | 0.3% |
CIPLA | -0.4% | 2.3% | -1.5% |
DR REDDYS LABORATORIES | 2.6% | -5.3% | 7% |
TORRENT PHARMACEUTICALS | 1.5% | 9.3% | 27.1% |
ABBOTT INDIA | 1.3% | -0.2% | 18.8% |
ZYDUS LIFESCIENCES | 0.3% | -1.9% | 41.3% |
ALKEM LABORATORIES | 0.8% | -5.8% | 9.5% |
FUNDAMENTAL ANALYSIS OF HESTER BIOSCIENCES
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF HESTER BIOSCIENCES
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
58.79
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 23.63 Cr
[Latest Qtr - Mar2023 - Consolidated Results ] 4.97
P/B Calculated based on Book Value of Rs 279.73 Cr
[Latest Year - Mar2023 - Consolidated Results ] 5.22
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 266.09 Cr
[Latest Qtr - Mar2023 - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
650% 216% 177% |
SHARE PRICE MOMENTUM OF HESTER BIOSCIENCES
HESTER BIOSCIENCES vs SENSEX
DEBT OF HESTER BIOSCIENCES
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2022 2021 2020 Avg_3yrs |
0.45 0.07 0.24 0.25 |
0.86 0.46 0.6 0.64 |
[Last Annual Data : Mar2022]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF HESTER BIOSCIENCES
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Mar2023 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF HESTER BIOSCIENCES
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
-10.2% -37.76% -42.05% -46.79% |
19.18% 13.08% -25.37% -36.89% |
QtrlyTrend |
-4 | |
Latest Qtr: Mar2023 | ||
Quarterly Result Analysis → |
HESTER BIOSCIENCES related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE SMALL CAP | 3.3% | 7.1% | 18.8% |
S&P BSE HEALTHCARE | 3.2% | 5.1% | 10% |
S&P BSE MIDSMALLCAP | 2.9% | 6.7% | 19.4% |
S&P BSE ALLCAP | 1.6% | 3.9% | 13.8% |
You may also like the below Video Courses
FAQ about HESTER BIOSCIENCES
Is HESTER BIOSCIENCES good for long term investment?
As on Jun 07,2023, the Fundamentals of HESTER BIOSCIENCES look Strong and hence it may be good for long term investment! See Financial Performance of HESTER BIOSCIENCES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is HESTER BIOSCIENCES UnderValued or OverValued?
As on Jun 07,2023, HESTER BIOSCIENCES is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of HESTER BIOSCIENCES ?
As on Jun 07,2023, the Intrinsic Value of HESTER BIOSCIENCES is Rs. 516.75 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 217.63
Fair Value [Median EV / Sales Model] : Rs. 516.75
Fair Value [Median Price / Sales Model] : Rs. 589.46
Estimated Median Fair Value of HESTER BIOSCIENCES : Rs. 516.75
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.
Is HESTER BIOSCIENCES trading at a Premium or Discount?
As on Jun 07,2023, HESTER BIOSCIENCES is trading at a Premium of 216% based on the estimates of Median Intrinsic Value!